Urinary NGAL Acute Kidney Injury After Stored Red Blood Cells Transfusion in Critically Ill Patients.
NCT ID: NCT03560921
Last Updated: 2018-06-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
147 participants
OBSERVATIONAL
2017-06-02
2017-12-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
NCT01294228
Acute Kidney Injury as a Risk Factor for Myocardial Injury After Non Cardiac Surgery
NCT05068167
Study of Accuracy of NGAL, a Renal Injury Biomarker, in Patients With Cirrhosis
NCT02049125
Evaluation of Novel Biomarkers From Acutely Ill Patients at Risk for Acute Kidney Injury
NCT01209169
Preventing Acute Kidney Injury and Improving Outcome in Critically Ill Patients Utilising Risk Prediction Score
NCT03178435
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Stored blood transfusion
measurement of urinary NGAL
urinary NGAL
measurement urinary NGAL using the ARCHITECT technique
Fresh blood transfusion
measurement of urinary NGAL
urinary NGAL
measurement urinary NGAL using the ARCHITECT technique
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
urinary NGAL
measurement urinary NGAL using the ARCHITECT technique
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kasr El Aini Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tarek Samy Abdelziz
Senior lecturer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tarek Abdelaziz
Role: PRINCIPAL_INVESTIGATOR
faculty of medicine-Cairo University Hospitals
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cairo university hospitals
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KA-13115
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.